United States Biotechnology & Medical Research

Track

Verona Pharma PLC (VRNA)

Track

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: VRNA Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Cunningham Kenneth

1 sale — total 142,057 USD

Sale 1 Aug 2025

Value US$2,240,007.80 | Price 204.55 | Shares 21,007

Deschamps Lisa

1 sale — total 124,392 USD

Sale 1 Aug 2025

Value US$4,229,501.86 | Price 76.04 | Shares 14,069

Fisher Andrew

General Counsel

1 sale — total 125,969 USD

Sale 1 Aug 2025

Value US$125,969.22 | Price 13.14 | Shares 9,584

Rickard Kathleen A.

Chief Medical Officer

1 sale — total 766,751 USD

Planned sale 1 Aug 2025

Value US$766,750.88 | Price 13.14 | Shares 58,336

EBSWORTH DAVID R

1 sale — total 25,026 USD

Sale 1 Aug 2025

Value US$25,025.60 | Price 13.14 | Shares 1,904

ACKERMANN CHRISTINA

1 sale — total 23,764 USD

Sale 1 Aug 2025

Value US$23,763.81 | Price 13.14 | Shares 1,808

ZACCARDELLI DAVID

President and CEO

1 sale — total 2,745,877 USD

Planned sale 1 Aug 2025

Value US$2,745,876.65 | Price 13.14 | Shares 208,912

Hahn Mark W

Chief Financial Officer

1 sale — total 2,745,877 USD

Planned sale 1 Aug 2025

Value US$2,745,876.65 | Price 13.14 | Shares 208,912

Austwick Michael

1 sale — total 148,366 USD

Sale 1 Aug 2025

Value US$148,366.09 | Price 13.14 | Shares 11,288

Brady James Aloysius

1 sale — total 10,830 USD

Sale 1 Aug 2025

Value US$10,830.41 | Price 13.14 | Shares 824

Edwards Martin

1 sale — total 142,057 USD

Sale 1 Aug 2025

Value US$142,057.11 | Price 13.14 | Shares 10,808

SHAH MAHENDRA

1 sale — total 47,422 USD

Sale 1 Aug 2025

Value US$47,422.47 | Price 13.14 | Shares 3,608

Sinha Vikas

1 sale — total 56,886 USD

Sale 1 Aug 2025

Value US$56,885.93 | Price 13.14 | Shares 4,328

Fisher Andrew

General Counsel

1 sale — total 922,000 USD

Planned sale 16 Jun 2025

Value US$922,000.00 | Price 11.53 | Shares 80,000

ZACCARDELLI DAVID

President and CEO

1 sale — total 4,560,520 USD

Planned sale 11 Jun 2025

Value US$4,560,520.00 | Price 11.40 | Shares 400,000

Hahn Mark W

Chief Financial Officer

1 sale — total 4,560,360 USD

Planned sale 11 Jun 2025

Value US$4,560,360.00 | Price 11.40 | Shares 400,000

DAVID ZACCARDELLI

Director; Officer

1 sale — total 4,339,000 USD

Proposed sale 11 Jun 2025

Value US$4,339,000.00 | Price 86.78 | Shares 50,000

MARK HAHN

Officer

1 sale — total 4,339,000 USD

Proposed sale 11 Jun 2025

Value US$4,339,000.00 | Price 86.78 | Shares 50,000

Hahn Mark W

Chief Financial Officer

1 sale — total 1,911,668 USD

Planned sale 29 May 2025

Value US$1,911,667.93 | Price 9.33 | Shares 204,864

ZACCARDELLI DAVID

President and CEO

1 sale — total 1,947,593 USD

Planned sale 29 May 2025

Value US$1,947,592.81 | Price 9.33 | Shares 208,696

Hahn Mark W

Chief Financial Officer

1 sale — total 1,513,294 USD

Planned sale 28 May 2025

Value US$1,513,293.63 | Price 9.30 | Shares 162,704

ZACCARDELLI DAVID

President and CEO

1 sale — total 1,466,805 USD

Planned sale 28 May 2025

Value US$1,466,804.90 | Price 9.30 | Shares 157,704

Hahn Mark W

Chief Financial Officer

1 sale — total 308,983 USD

Planned sale 27 May 2025

Value US$308,982.91 | Price 9.53 | Shares 32,432

ZACCARDELLI DAVID

President and CEO

1 sale — total 320,181 USD

Planned sale 27 May 2025

Value US$320,181.12 | Price 9.53 | Shares 33,600

DAVID ZACCARDELLI

Director; Officer

1 sale — total 3,753,000 USD

Proposed sale 27 May 2025

Value US$3,753,000.00 | Price 75.06 | Shares 50,000

MARK HAHN

Officer

1 sale — total 3,753,000 USD

Proposed sale 27 May 2025

Value US$3,753,000.00 | Price 75.06 | Shares 50,000

Sinha Vikas

1 sale — total 1,502,928 USD

Planned sale 20 May 2025

Value US$1,502,928.00 | Price 9.39 | Shares 160,000

VIKAS SINHA

Director

1 sale — total 1,451,600 USD

Proposed sale 20 May 2025

Value US$1,451,600.00 | Price 72.58 | Shares 20,000

Fisher Andrew

General Counsel

1 sale — total 685,600 USD

Planned sale 15 May 2025

Value US$685,600.00 | Price 8.57 | Shares 80,000

ANDREW FISHER

Officer

1 sale — total 2,017,200 USD

Proposed sale 15 May 2025

Value US$2,017,200.00 | Price 67.24 | Shares 30,000

ACKERMANN CHRISTINA

1 sale — total 337,600 USD

Planned sale 14 May 2025

Value US$337,600.00 | Price 8.44 | Shares 40,000

CHRISTINA ACKERMANN

Director

1 sale — total 337,850 USD

Proposed sale 14 May 2025

Value US$337,850.00 | Price 67.57 | Shares 5,000

Rickard Kathleen A.

Chief Medical Officer

1 sale — total 1,014,343 USD

Planned sale 6 May 2025

Value US$1,014,342.85 | Price 8.82 | Shares 114,984

KATHLEEN RICKARD

Officer

1 sale — total 1,038,449 USD

Proposed sale 6 May 2025

Value US$1,038,449.25 | Price 72.25 | Shares 14,373

Hahn Mark W

Chief Financial Officer

1 sale — total 3,637,720 USD

Planned sale 2 May 2025

Value US$3,637,720.00 | Price 9.09 | Shares 400,000

ZACCARDELLI DAVID

President and CEO

1 sale — total 3,637,520 USD

Planned sale 2 May 2025

Value US$3,637,520.00 | Price 9.09 | Shares 400,000

MARK HAHN

Officer

1 sale — total 3,613,000 USD

Proposed sale 2 May 2025

Value US$3,613,000.00 | Price 72.26 | Shares 50,000

DAVID ZACCARDELLI

Director; Officer

1 sale — total 3,613,000 USD

Proposed sale 2 May 2025

Value US$3,613,000.00 | Price 72.26 | Shares 50,000

Hahn Mark W

Chief Financial Officer

2 sales — total 1,673,759 USD

Planned sale 1 May 2025

Value US$704,702.95 | Price 8.95 | Shares 78,736

Planned sale 1 May 2025

Value US$969,056.05 | Price 8.95 | Shares 108,272

Rickard Kathleen A.

Chief Medical Officer

2 sales — total 440,350 USD

Planned sale 1 May 2025

Value US$195,687.17 | Price 8.95 | Shares 21,864

Planned sale 1 May 2025

Value US$244,662.67 | Price 8.95 | Shares 27,336

ZACCARDELLI DAVID

President and CEO

2 sales — total 1,673,759 USD

Planned sale 1 May 2025

Value US$704,702.95 | Price 8.95 | Shares 78,736

Planned sale 1 May 2025

Value US$969,056.05 | Price 8.95 | Shares 108,272

Sinha Vikas

2 sales — total 178,416 USD

Planned sale 29 Apr 2025

Value US$44,175.80 | Price 8.92 | Shares 4,952

Planned sale 29 Apr 2025

Value US$134,240.20 | Price 8.92 | Shares 15,048

Hahn Mark W

Chief Financial Officer

1 sale — total 811,433 USD

Planned sale 29 Apr 2025

Value US$811,432.80 | Price 8.98 | Shares 90,360

Rickard Kathleen A.

Chief Medical Officer

1 sale — total 308,768 USD

Planned sale 29 Apr 2025

Value US$308,768.32 | Price 8.98 | Shares 34,384

ZACCARDELLI DAVID

President and CEO

1 sale — total 811,433 USD

Planned sale 29 Apr 2025

Value US$811,432.80 | Price 8.98 | Shares 90,360

Fisher Andrew

General Counsel

1 sale — total 234,127 USD

Sale 29 Apr 2025

Value US$234,126.56 | Price 8.98 | Shares 26,072

VIKAS SINHA

Director

1 sale — total 1,376,600 USD

Proposed sale 29 Apr 2025

Value US$1,376,600.00 | Price 68.83 | Shares 20,000

Rickard Kathleen A.

Chief Medical Officer

1 sale — total 661,942 USD

Planned sale 12 Mar 2025

Value US$661,941.59 | Price 8.35 | Shares 79,264

KATHLEEN RICKARD

Officer

1 sale — total 621,232 USD

Proposed sale 12 Mar 2025

Value US$621,231.60 | Price 62.70 | Shares 9,908

Hahn Mark W

Chief Financial Officer

1 sale — total 920,312 USD

Planned sale 6 Dec 2024

Value US$920,311.92 | Price 5.01 | Shares 183,728

ZACCARDELLI DAVID

President and CEO

1 sale — total 815,400 USD

Planned sale 6 Dec 2024

Value US$815,400.08 | Price 5.01 | Shares 162,800

Hahn Mark W

Chief Financial Officer

1 sale — total 3,204,144 USD

Planned sale 5 Dec 2024

Value US$3,204,144.29 | Price 5.01 | Shares 640,048

ZACCARDELLI DAVID

President and CEO

1 sale — total 3,205,226 USD

Planned sale 5 Dec 2024

Value US$3,205,225.61 | Price 5.01 | Shares 640,264

Hahn Mark W

Chief Financial Officer

1 sale — total 290,996 USD

Planned sale 4 Dec 2024

Value US$290,995.64 | Price 5.00 | Shares 58,184

ZACCARDELLI DAVID

President and CEO

1 sale — total 338,162 USD

Planned sale 4 Dec 2024

Value US$338,161.69 | Price 5.00 | Shares 67,608

Hahn Mark W

Chief Financial Officer

1 sale — total 8,000 USD

Planned sale 2 Dec 2024

Value US$8,000.00 | Price 5.00 | Shares 1,600

ZACCARDELLI DAVID

President and CEO

1 sale — total 16,000 USD

Planned sale 2 Dec 2024

Value US$16,000.00 | Price 5.00 | Shares 3,200

Hahn Mark W

Chief Financial Officer

1 sale — total 494,142 USD

Planned sale 29 Nov 2024

Value US$494,141.84 | Price 5.01 | Shares 98,704

ZACCARDELLI DAVID

President and CEO

1 sale — total 495,033 USD

Planned sale 29 Nov 2024

Value US$495,033.33 | Price 5.01 | Shares 98,888

Hahn Mark W

Chief Financial Officer

1 sale — total 64,680 USD

Planned sale 27 Nov 2024

Value US$64,680.00 | Price 5.00 | Shares 12,936

ZACCARDELLI DAVID

President and CEO

1 sale — total 116,200 USD

Planned sale 27 Nov 2024

Value US$116,200.00 | Price 5.00 | Shares 23,240

Hahn Mark W

Chief Financial Officer

1 sale — total 4,000 USD

Planned sale 26 Nov 2024

Value US$4,000.00 | Price 5.00 | Shares 800

ZACCARDELLI DAVID

President and CEO

1 sale — total 8,000 USD

Planned sale 25 Nov 2024

Value US$8,000.00 | Price 5.00 | Shares 1,600

Hahn Mark W

Chief Financial Officer

1 sale — total 8,000 USD

Planned sale 25 Nov 2024

Value US$8,000.00 | Price 5.00 | Shares 1,600

Rickard Kathleen A.

Chief Medical Officer

1 sale — total 1,176,360 USD

Planned sale 25 Nov 2024

Value US$1,176,360.00 | Price 4.90 | Shares 240,000

KATHLEEN A RICKARD

Officer

1 sale — total 1,176,357 USD

Proposed sale 25 Nov 2024

Value US$1,176,357.00 | Price 39.21 | Shares 30,000

EBSWORTH DAVID R

1 purchase — total 88,800 USD

Buy 18 Nov 2024

Value US$88,800.00 | Price 4.44 | Shares 20,000

Hahn Mark W

Chief Financial Officer

1 sale — total 12,000 USD

Planned sale 11 Nov 2024

Value US$12,000.00 | Price 5.00 | Shares 2,400

ZACCARDELLI DAVID

President and CEO

1 sale — total 12,000 USD

Planned sale 11 Nov 2024

Value US$12,000.00 | Price 5.00 | Shares 2,400

MARK HAHN

Officer

1 sale — total 4,822,500 USD

Proposed sale 11 Nov 2024

Value US$4,822,500.00 | Price 38.58 | Shares 125,000

DAVID ZACCARDELLI

Director; Officer

1 sale — total 4,822,500 USD

Proposed sale 11 Nov 2024

Value US$4,822,500.00 | Price 38.58 | Shares 125,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-08-05	2025-08-01	S Sale	Cunningham Kenneth Non-Executive Director	21,007 +42.2% 204.55 US$2,240,008	21,007 +42.2%	204.55	US$2,240,008
2025-08-05	2025-08-01	S Sale	Deschamps Lisa Non-Executive Director	14,069 -6.1% 76.04 US$4,229,502	14,069 -6.1%	76.04	US$4,229,502
2025-08-05	2025-08-01	S Sale	3.3 Fisher Andrew General Counsel Officer	8,595 +12.5% 116.71 US$2,410,077	8,595 +12.5%	116.71	US$2,410,077
2025-08-05	2025-08-01	PlS Planned sale	Rickard Kathleen A. Chief Medical Officer Officer	58,336 -2.2% 13.14 US$766,751	58,336 -2.2%	13.14	US$766,751
2025-08-05	2025-08-01	S Sale	EBSWORTH DAVID R Non-Executive Director	1,904 -0.2% 13.14 US$25,026	1,904 -0.2%	13.14	US$25,026
2025-08-05	2025-08-01	S Sale	2.2 ACKERMANN CHRISTINA Non-Executive Director	1,808 -2.7% 13.14 US$23,764	1,808 -2.7%	13.14	US$23,764
2025-08-05	2025-08-01	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	208,912 -1.5% 13.14 US$2,745,877	208,912 -1.5%	13.14	US$2,745,877
2025-08-05	2025-08-01	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	208,912 -1.6% 13.14 US$2,745,877	208,912 -1.6%	13.14	US$2,745,877
2025-08-05	2025-08-01	S Sale	Austwick Michael Non-Executive Director	11,288 -47.0% 13.14 US$148,366	11,288 -47.0%	13.14	US$148,366
2025-08-05	2025-08-01	S Sale	Brady James Aloysius Non-Executive Director	824 -3.4% 13.14 US$10,830	824 -3.4%	13.14	US$10,830
2025-08-05	2025-08-01	S Sale	3.4 Edwards Martin Non-Executive Director	10,808 -6.4% 13.14 US$142,057	10,808 -6.4%	13.14	US$142,057
2025-08-05	2025-08-01	S Sale	SHAH MAHENDRA Non-Executive Director	3,608 -3.7% 13.14 US$47,422	3,608 -3.7%	13.14	US$47,422
2025-08-05	2025-08-01	S Sale	2.7 Sinha Vikas Non-Executive Director	4,328 -4.4% 13.14 US$56,886	4,328 -4.4%	13.14	US$56,886
2025-06-18	2025-06-16	PlS Planned sale	3.3 Fisher Andrew General Counsel Officer	80,000 -18.2% 11.53 US$922,000	80,000 -18.2%	11.53	US$922,000
2025-06-13	2025-06-11	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	400,000 -2.9% 11.40 US$4,560,520	400,000 -2.9%	11.40	US$4,560,520
2025-06-13	2025-06-11	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	400,000 -3.2% 11.40 US$4,560,360	400,000 -3.2%	11.40	US$4,560,360
2025-06-11	2025-06-11	PrS Proposed sale	DAVID ZACCARDELLI Director; Officer Executive Director	50,000 86.78 US$4,339,000	50,000	86.78	US$4,339,000
2025-06-11	2025-06-11	PrS Proposed sale	MARK HAHN Officer Officer	50,000 86.78 US$4,339,000	50,000	86.78	US$4,339,000
2025-05-29	2025-05-29	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	204,864 -1.6% 9.33 US$1,911,668	204,864 -1.6%	9.33	US$1,911,668
2025-05-29	2025-05-29	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	208,696 -1.5% 9.33 US$1,947,593	208,696 -1.5%	9.33	US$1,947,593
2025-05-29	2025-05-28	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	162,704 -1.2% 9.30 US$1,513,294	162,704 -1.2%	9.30	US$1,513,294
2025-05-29	2025-05-28	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	157,704 -1.1% 9.30 US$1,466,805	157,704 -1.1%	9.30	US$1,466,805
2025-05-29	2025-05-27	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	32,432 -0.2% 9.53 US$308,983	32,432 -0.2%	9.53	US$308,983
2025-05-29	2025-05-27	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	33,600 -0.2% 9.53 US$320,181	33,600 -0.2%	9.53	US$320,181
2025-05-27	2025-05-27	PrS Proposed sale	DAVID ZACCARDELLI Director; Officer Executive Director	50,000 75.06 US$3,753,000	50,000	75.06	US$3,753,000
2025-05-27	2025-05-27	PrS Proposed sale	MARK HAHN Officer Officer	50,000 75.06 US$3,753,000	50,000	75.06	US$3,753,000
2025-05-22	2025-05-20	PlS Planned sale	2.7 Sinha Vikas Non-Executive Director	160,000 -68.2% 9.39 US$1,502,928	160,000 -68.2%	9.39	US$1,502,928
2025-05-20	2025-05-20	PrS Proposed sale	2.7 VIKAS SINHA Director Non-Executive Director	20,000 72.58 US$1,451,600	20,000	72.58	US$1,451,600
2025-05-16	2025-05-15	PlS Planned sale	3.3 Fisher Andrew General Counsel Officer	80,000 -18.2% 8.57 US$685,600	80,000 -18.2%	8.57	US$685,600
2025-05-15	2025-05-15	PrS Proposed sale	3.3 ANDREW FISHER Officer Officer	30,000 67.24 US$2,017,200	30,000	67.24	US$2,017,200
2025-05-16	2025-05-14	PlS Planned sale	2.2 ACKERMANN CHRISTINA Non-Executive Director	40,000 -48.9% 8.44 US$337,600	40,000 -48.9%	8.44	US$337,600
2025-05-14	2025-05-14	PrS Proposed sale	2.2 CHRISTINA ACKERMANN Director Non-Executive Director	5,000 67.57 US$337,850	5,000	67.57	US$337,850
2025-05-08	2025-05-06	PlS Planned sale	Rickard Kathleen A. Chief Medical Officer Officer	114,984 -4.3% 8.82 US$1,014,343	114,984 -4.3%	8.82	US$1,014,343
2025-05-06	2025-05-06	PrS Proposed sale	KATHLEEN RICKARD Officer Officer	14,373 72.25 US$1,038,449	14,373	72.25	US$1,038,449
2025-05-05	2025-05-02	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	400,000 -3.0% 9.09 US$3,637,720	400,000 -3.0%	9.09	US$3,637,720
2025-05-05	2025-05-02	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	400,000 -2.8% 9.09 US$3,637,520	400,000 -2.8%	9.09	US$3,637,520
2025-05-02	2025-05-02	PrS Proposed sale	MARK HAHN Officer Officer	50,000 72.26 US$3,613,000	50,000	72.26	US$3,613,000
2025-05-02	2025-05-02	PrS Proposed sale	DAVID ZACCARDELLI Director; Officer Executive Director	50,000 72.26 US$3,613,000	50,000	72.26	US$3,613,000
2025-05-05	2025-05-01	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	78,736 -0.6% 8.95 US$704,703	78,736 -0.6%	8.95	US$704,703
2025-05-05	2025-05-01	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	108,272 -0.8% 8.95 US$969,056	108,272 -0.8%	8.95	US$969,056
2025-05-05	2025-05-01	PlS Planned sale	Rickard Kathleen A. Chief Medical Officer Officer	21,864 -0.8% 8.95 US$195,687	21,864 -0.8%	8.95	US$195,687
2025-05-05	2025-05-01	PlS Planned sale	Rickard Kathleen A. Chief Medical Officer Officer	27,336 -1.0% 8.95 US$244,663	27,336 -1.0%	8.95	US$244,663
2025-05-05	2025-05-01	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	78,736 -0.5% 8.95 US$704,703	78,736 -0.5%	8.95	US$704,703
2025-05-05	2025-05-01	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	108,272 -0.8% 8.95 US$969,056	108,272 -0.8%	8.95	US$969,056
2025-05-01	2025-04-29	PlS Planned sale	2.7 Sinha Vikas Non-Executive Director	4,952 -6.2% 8.92 US$44,176	4,952 -6.2%	8.92	US$44,176
2025-05-01	2025-04-29	PlS Planned sale	2.7 Sinha Vikas Non-Executive Director	15,048 -16.8% 8.92 US$134,240	15,048 -16.8%	8.92	US$134,240
2025-05-01	2025-04-29	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	90,360 -0.7% 8.98 US$811,433	90,360 -0.7%	8.98	US$811,433
2025-05-01	2025-04-29	PlS Planned sale	Rickard Kathleen A. Chief Medical Officer Officer	34,384 -1.3% 8.98 US$308,768	34,384 -1.3%	8.98	US$308,768
2025-05-01	2025-04-29	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	90,360 -0.6% 8.98 US$811,433	90,360 -0.6%	8.98	US$811,433
2025-05-01	2025-04-29	S Sale	3.3 Fisher Andrew General Counsel Officer	26,072 -6.8% 8.98 US$234,127	26,072 -6.8%	8.98	US$234,127
2025-04-29	2025-04-29	PrS Proposed sale	2.7 VIKAS SINHA Director Non-Executive Director	20,000 68.83 US$1,376,600	20,000	68.83	US$1,376,600
2025-03-13	2025-03-12	PlS Planned sale	Rickard Kathleen A. Chief Medical Officer Officer	79,264 -2.9% 8.35 US$661,942	79,264 -2.9%	8.35	US$661,942
2025-03-12	2025-03-12	PrS Proposed sale	KATHLEEN RICKARD Officer Officer	9,908 62.70 US$621,232	9,908	62.70	US$621,232
2024-12-06	2024-12-06	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	183,728 -1.4% 5.01 US$920,312	183,728 -1.4%	5.01	US$920,312
2024-12-06	2024-12-06	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	162,800 -1.1% 5.01 US$815,400	162,800 -1.1%	5.01	US$815,400
2024-12-06	2024-12-05	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	640,048 -4.5% 5.01 US$3,204,144	640,048 -4.5%	5.01	US$3,204,144
2024-12-06	2024-12-05	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	640,264 -4.3% 5.01 US$3,205,226	640,264 -4.3%	5.01	US$3,205,226
2024-12-06	2024-12-04	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	58,184 -0.4% 5.00 US$290,996	58,184 -0.4%	5.00	US$290,996
2024-12-06	2024-12-04	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	67,608 -0.4% 5.00 US$338,162	67,608 -0.4%	5.00	US$338,162
2024-12-02	2024-12-02	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	1,600 -0.0% 5.00 US$8,000	1,600 -0.0%	5.00	US$8,000
2024-12-02	2024-12-02	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	3,200 -0.0% 5.00 US$16,000	3,200 -0.0%	5.00	US$16,000
2024-12-02	2024-11-29	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	98,704 -0.7% 5.01 US$494,142	98,704 -0.7%	5.01	US$494,142
2024-12-02	2024-11-29	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	98,888 -0.7% 5.01 US$495,033	98,888 -0.7%	5.01	US$495,033
2024-12-02	2024-11-27	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	12,936 -0.1% 5.00 US$64,680	12,936 -0.1%	5.00	US$64,680
2024-12-02	2024-11-27	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	23,240 -0.2% 5.00 US$116,200	23,240 -0.2%	5.00	US$116,200
2024-11-26	2024-11-26	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	800 -0.0% 5.00 US$4,000	800 -0.0%	5.00	US$4,000
2024-11-26	2024-11-25	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	1,600 -0.0% 5.00 US$8,000	1,600 -0.0%	5.00	US$8,000
2024-11-26	2024-11-25	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	1,600 -0.0% 5.00 US$8,000	1,600 -0.0%	5.00	US$8,000
2024-11-26	2024-11-25	PlS Planned sale	Rickard Kathleen A. Chief Medical Officer Officer	240,000 -8.2% 4.90 US$1,176,360	240,000 -8.2%	4.90	US$1,176,360
2024-11-25	2024-11-25	PrS Proposed sale	KATHLEEN A RICKARD Officer Officer	30,000 39.21 US$1,176,357	30,000	39.21	US$1,176,357
2024-11-18	2024-11-18	B Purchase	EBSWORTH DAVID R Non-Executive Director	20,000 +2.2% 4.44 US$88,800	20,000 +2.2%	4.44	US$88,800
2024-11-13	2024-11-11	PlS Planned sale	Hahn Mark W Chief Financial Officer Officer	2,400 -0.0% 5.00 US$12,000	2,400 -0.0%	5.00	US$12,000
2024-11-13	2024-11-11	PlS Planned sale	ZACCARDELLI DAVID President and CEO Executive Director	2,400 -0.0% 5.00 US$12,000	2,400 -0.0%	5.00	US$12,000
2024-11-12	2024-11-11	PrS Proposed sale	MARK HAHN Officer Officer	125,000 38.58 US$4,822,500	125,000	38.58	US$4,822,500
2024-11-12	2024-11-11	PrS Proposed sale	DAVID ZACCARDELLI Director; Officer Executive Director	125,000 38.58 US$4,822,500	125,000	38.58	US$4,822,500